Autoinjectors Market Size to Reach USD 170.16 Billion in 2028 Growing at a CAGR of 17.7%, according to Emergen Research

Emergen Research has published its latest report titled “Autoinjectors Market By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes, Other), By Type (Disposable, Reusable), By Route of Administration (Subcutaneous, Intramuscular) By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings), and By Region Forecast to 2028”

According to Emergen Research, the global autoinjectors market size was USD 45.89 Billion in 2020 and is expected to reach USD 170.16 Billion in 2028 and register a revenue CAGR of 17.7% during the forecast period, 2021-2028.

Market Dynamics:

An autoinjector is a medical device that is used to deliver a specific medicine dose. Initially, the injectors were created to help people overcome their fear of using a needle-based medication delivery system on their own. There are many risks and challenges involved in administering an injection, both physical and psychological. But, the use of an auto-injector can provide numerous advantages to both the healthcare providers and users. It allows medication to be administered more quickly and with a better bioavailability as it delivers the medicine with a spray effect during administration. It is convenient and is able to reduce needle phobia since the needle is contained inside the vial. This is a key factor boosting adoption of autoinjectors and is expected to drive global market revenue growth over the forecast period. In addition, medical management is extremely challenging in the situation of natural disasters, as hospital access is either impossible or complicated. Autoinjectors are extremely beneficial in such or emergency cases since it allow for self-administration.

Autoinjector technology has advanced significantly in recent years, and recent advances are expanding application scope of innovative devices for a wide range of therapies. Epinephrine autoinjectors are one of the most popular types of autoinjectors, which is a pocket-sized medicine used for anaphylactic shock treatment. Epinephrine is a life-saving medication that reduces the swelling of the airway during a severe allergic reaction. However, lack of awareness on how to use an autoinjector, availability of alternative healthcare treatment options such as oral tablets are some factors which can restrain autoinjector market growth over the forecast period.

Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/678

COVID-19 Impact Analysis  

  • Social distancing and restrictions severely disrupted businesses and operations
  • Lockdowns caused disruptions in transportation and logistics
  • Impacted manufacturing activities and mining operations globally
  • Took a toll on economy of various countries
  • Caused sudden and drastic downturn in economic activity
  • Disrupted agriculture, fisheries, dairy, and other sectors
  • Caused loss of employment and financial crisis
  • Supply impacts were further compounded owing to reduced disposable income
  • Emergence of variants  continue to cause concerns and impact normal routines

Rheumatoid Arthritis Segment Revenue to Expand at a Rapid CAGR:

Rheumatoid arthritis segment is expected to register a rapid revenue CAGR over the forecast period owing to increasing prevalence of rheumatoid arthritis globally. Rheumatoid arthritis (RA) is a condition that causes inflammation and pain in the joints. It affects people of all ages, although the elderly population is particularly vulnerable to the condition. RA can harm a range of body systems in some people, including the eyes, lungs, skin, heart, and blood vessels.

Home Care Settings Segment to Register Significant Revenue Growth:

Home care settings segment is expected to register significant revenue growth over the forecast period due to growing popularity of telehealth, technological advancements of home care devices, rapid growth in the elderly population and increasing healthcare costs have resulted in patient preference towards home care therapeutic treatments.

North America to Account for Largest Revenue Share:

North America is expected to account for largest revenue share in the global market over the forecast period due to ongoing technological advancements in medical devices, increasing number of patients suffering from diabetes and anaphylaxis, and favorable government policies. Further, increasing demand for home healthcare devices and robust presence of key players are other factors expected to contribute to market growth in the region.

Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/678

Major Companies in the Market Include:

  • Braun Melsungen AG
  • AbbVie Inc.
  • Mylan, Eli Lilly and Company
  • Ypsomed
  • Amgen
  • Becton
  • Dickinson and Company
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Antares Pharma

For the purpose of this report, Emergen Research has segmented the global autoinjectors market based on therapy, type, route of administration, end-use, and region:

Therapy Outlook (Revenue, USD Billion; 2018–2028)

  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Anaphylaxis
  • Diabetes
  • Others

Type Outlook (Revenue, USD Billion; 2018–2028)

  • Disposable
  • Reusable

Route of Administration Outlook (Revenue, USD Billion; 2018-2028)

  • Subcutaneous
  • Intramuscular

End-Use Outlook (Revenue, USD Billion; 2018–2028)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/autoinjectors-market

Regional Outlook (Revenue, USD Billion; 2018–2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East & Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Turkey
    • Rest of MEA

Explore Blogs offered by Emergen Research:

Top 10 Leading Companies Offering Path-breaking Blockchain AI Solutions

Top 7 Companies Offering Blockchain Technology In Energy Sector

Top 10 IoT Medical Device Companies Leading the Digital Revolution in Healthcare

Top 10 Companies in the AI-Enabled Medical Imaging Solutions Market

Top 10 Healthcare Business Intelligence Companies In The World

Top 10 Globally Renowned Companies Offering Robust Crop Monitoring Systems

Top 9 Globally Renowned Companies Offering Cloud Billing Services

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs

Full Press Release@ https://www.emergenresearch.com/press-release/global-autoinjectors-market

Back to news